HB 1299 allows small lodging establishments (with 15 or fewer sleeping rooms) to apply for a permit to use biological filtration systems in their water recreational facilities, such as pools or spas. These systems filter water naturally using plants, beneficial bacteria, and microbes - without relying on continuous chemical disinfectants - to meet public health and safety standards. To obtain a permit, establishments must submit proof the system meets water quality requirements, pay a $50 fee, and undergo annual department inspections. If an inspection fails, the permit is revoked, and reapplication is barred for one year. The bill requires the department to establish rules for applications, maintenance, and testing procedures.
HB 1292 limits South Dakota health insurance companies' ability to take back payments they've already made for medical services. It requires insurers to provide written notice at least 30 days in advance if they seek to recoup a payment, and restricts such actions to claims paid within the previous 18 months (with exceptions for fraud, Medicare/Medicaid, workers' compensation, or duplicate payments). The bill establishes a dispute resolution process through the Division of Insurance for disagreements, preventing insurers from withholding future payments during the review. This directly affects healthcare providers (like doctors and clinics) who receive payments from insurers and the insurers themselves, applying to claims for services provided on or after July 1, 2026.
SB 89 requires all South Dakota counties and municipalities to ensure a minimum level of emergency medical services (including response times, staffing, and treatment protocols) are available within their boundaries for prehospital care. It directs the state health department to create rules defining these minimum standards, covering aspects like ambulance response and required personnel. The bill also establishes a legislative task force to study funding mechanisms for these services and report recommendations by November 2026. The law would take effect on July 1, 2028, impacting local governments responsible for emergency medical service provision.
HB 1149 adopts the Athletic Trainer Licensure Compact, allowing South Dakota to join a multi-state agreement that enables licensed athletic trainers from participating states to practice in South Dakota without obtaining a separate license. The bill requires athletic trainers seeking to practice under the compact to undergo a fingerprint-based criminal background check (paid by the trainer) and establishes mutual recognition of licenses across member states. Key provisions include reducing administrative burdens for trainers, improving access to athletic care through streamlined interstate practice, and ensuring states maintain authority to regulate practice within their borders. This directly affects athletic trainers seeking to work across state lines and patients in South Dakota who may access care from out-of-state professionals.
HB 1183 revises South Dakota's law granting immunity from prosecution for drug possession charges after an overdose. It directly affects individuals experiencing a drug-related overdose who contact emergency services for medical help. The key change specifies that immunity only applies if the evidence used for any charges stems from the overdose event itself and the need for medical assistance. This clarifies eligibility for the existing immunity provision, requiring that the evidence leading to prosecution originated during the overdose situation. The bill does not expand immunity but refines the conditions under which it applies.
This bill creates a taskforce to study how South Dakota could establish Medicaid managed care entities specifically serving tribal communities, as defined under federal law. The taskforce includes representatives from all federally recognized South Dakota tribes, state health and social services agencies, healthcare providers, insurance companies, and tribal relations officials. It must gather input from stakeholders and submit findings and potential legislation to the Governor by December 2028. The bill does not implement new programs but sets a process for evaluating this option.
HB 1099 would reclassify FDA-approved psilocybin medications from Schedule I to Schedule IV under South Dakota law. This change would allow medical providers to prescribe these specific pharmaceutical products without the strict restrictions currently applied to Schedule I substances. The bill specifically affects only psilocybin in drug products approved by the FDA, not raw psilocybin or unapproved formulations. This amendment aligns South Dakota's scheduling with federal approval status for medical use.
HB 1164 makes it a Class 5 felony for licensed healthcare providers to use reproductive material (like sperm or eggs) without a patient’s written consent during assisted reproduction procedures (e.g., IVF). It directly affects healthcare providers, patients, donors, and children born from such procedures. The bill establishes civil liability, allowing patients, spouses, intended parents, children, or donors to sue for $10,000 in liquidated damages plus other costs and attorney fees. Lawsuits must be filed within five years of the child’s 18th birthday or when evidence (like DNA results) is discovered.
HB 1101 prohibits insurers from denying or limiting life, disability, or long-term care insurance coverage solely because someone is a living organ donor. It specifically bans insurers from: (1) refusing coverage based on donor status, (2) requiring donors to stop donating to maintain coverage, or (3) charging higher premiums or imposing other restrictions due to donor status alone. The bill ensures that living organ donors cannot face insurance discrimination without evidence of actual increased health risk. This directly protects individuals who donate organs while alive from unfair treatment by insurance companies.
HB 1143 allows students with diabetes to possess and self-administer nasal glucagon (a medication for severe low blood sugar) on school property or at school events. It directly affects students diagnosed with diabetes who require this specific treatment. The bill requires a licensed healthcare provider’s diagnosis, written parent authorization, and a physician’s statement detailing the medication’s purpose, dosage, and administration guidelines to be kept on file at the school. Schools must maintain these documents in the student’s health record or with the school nurse. This change expands existing provisions for asthma and anaphylaxis medications to include nasal glucagon for diabetes management.
